Vivanza Biosciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 7.84 | 0.19 | 0.77 |
| Operating Expense | 7.74 | 1.07 | 0.64 |
| Net Profit | 0.02 | -0.97 | 0.04 |
| Net Profit Margin | 0.26 | -510.53 | 5.19 |
| Earning Per Share | TBA | -0.24 | 0.01 |
| EBIDTA | 0.10 | -0.89 | 0.13 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 7.84 |
| Operating Expense | 7.74 |
| Net Profit | 0.02 |
| Net Profit Margin | 0.26 |
| Earning Per Share | TBA |
| EBIDTA | 0.10 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 2.94 | 14.41 | 14.21 |
| Operating Expenses Annual | 3.31 | 13.61 | 13.49 |
| Operating Profit Annual | -0.33 | 0.85 | 1.11 |
| Interest Annual | 0.35 | 0.41 | 0.42 |
| Depreciation | 0.01 | 0.01 | 0.00 |
| Net Profit Annual | -0.70 | 0.32 | 0.57 |
| Tax Annual | 0.00 | 0.11 | 0.12 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 2.94 |
| Operating Expenses Annual | 3.31 |
| Operating Profit Annual | -0.33 |
| Interest Annual | 0.35 |
| Depreciation | 0.01 |
| Net Profit Annual | -0.70 |
| Tax Annual | 0.00 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.09 | 0.10 | 0.02 |
| Cash Flow from Operations | -2.47 | 1.80 | 0.16 |
| Cash Flow from Investing | -0.01 | -0.04 | TBA |
| Cash Flow from Financing | 2.44 | -1.77 | -0.08 |
| Cash Flow at the End | 0.05 | 0.09 | 0.10 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.09 |
| Cash Flow from Operations | -2.47 |
| Cash Flow from Investing | -0.01 |
| Cash Flow from Financing | 2.44 |
| Cash Flow at the End | 0.05 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -11.22 | 5.97 | 7.88 |
| PBIT Margin (%) | -11.56 | 5.90 | 7.88 |
| PBT Margin (%) | 22.45 | -8.12 | -10.42 |
| Net PROFIT Margin (%) | -23.81 | 2.22 | 4.01 |
| Return On Networth / Equity (%) | -16.02 | 7.02 | 13.57 |
| Return On Networth /Employed (%) | -3.87 | 8.98 | 11.56 |
| Return On Assets (%) | -7.86 | 3.38 | 5.94 |
| Total Debt / Equity (X) | 1.07 | 1.08 | 1.33 |
| Asset Turnover Ratio (%) | 0.33 | 1.52 | 1.48 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -11.22 |
| PBIT Margin (%) | -11.56 |
| PBT Margin (%) | 22.45 |
| Net PROFIT Margin (%) | -23.81 |
| Return On Networth / Equity (%) | -16.02 |
| Return On Networth /Employed (%) | -3.87 |
| Return On Assets (%) | -7.86 |
| Total Debt / Equity (X) | 1.07 |
| Asset Turnover Ratio (%) | 0.33 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 0.02 | 0.03 | 0.00 |
| Total Current Assets Annual | 11.38 | 14.33 | 17.93 |
| Non Current Assets Annual | 2.53 | 2.54 | 2.51 |
| Total Shareholders Funds Annual | 4.02 | 4.72 | 4.40 |
| Total Assets Annual | 13.91 | 16.87 | 20.44 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 0.02 |
| Total Current Assets Annual | 11.38 |
| Non Current Assets Annual | 2.53 |
| Total Shareholders Funds Annual | 4.02 |
| Total Assets Annual | 13.91 |
EPS (INR)
Expected
0.02
Reported
0.02
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
